BRAF and colorectal carcinoma: Class III alterations, such as BRAF exon 15 p.D594A/G/H and BRAF exon 11 p.G466A/E/V, also make up approximately 12% of BRAF mutation in CRC,18, 20 leading to the formation of heterodimers.